BBIO vs CSL

Comparison between BridgeBio Pharma Inc (BBIO, Company) and Carlisle Companies Inc (CSL, Company).

BBIO is from the Healthcare sector, while CSL is from the Industrials sector.

5-Year PerformanceCSL has outperformed BBIO, delivering a return of +12.8% compared to +3.6%

BBIO vs CSL - Performance Comparison

Log

Key Characteristics

Financial metrics and valuation ratios

Metric	BBIO(COMPANY)	CSL(COMPANY)
Market Cap	$13B	$13B
Max Drawdown	92.80%	65.48%
Sharpe Ratio	1.75	-0.32
5Y Beta	1.08	1.00
Industry	Biotechnology	Building Products & Equipment
P/E Ratio	-18.09	18.72
Forward P/E	N/A	15.72
PEG Ratio	-3.23	1.04
Dividend Yield	N/A	1.31%
5Y Dividends CAGR	N/A	20.79%
5Y EPS CAGR	-3.14%	24.16%
Debt to Equity	-116.44%	174.73%
Free Cash Flow Yield	-3.33%	6.94%
P/S Ratio	23.04	2.67
P/B Ratio	123.68	7.97

Market Cap

Winner

BBIO

$13B

CSL

$13B

Max Drawdown

BBIO

92.80%

Winner

CSL

65.48%

Sharpe Ratio

Winner

BBIO

1.75

CSL

-0.32

5Y Beta

BBIO

1.08

Winner

CSL

1.00

Industry

BBIO

Biotechnology

CSL

Building Products & Equipment

P/E Ratio

Winner

BBIO

-18.09

CSL

18.72

Forward P/E

BBIO

N/A

CSL

15.72

PEG Ratio

Winner

BBIO

-3.23

CSL

1.04

Dividend Yield

BBIO

N/A

CSL

1.31%

5Y Dividends CAGR

BBIO

N/A

CSL

20.79%

5Y EPS CAGR

BBIO

-3.14%

Winner

CSL

24.16%

Debt to Equity

Winner

BBIO

-116.44%

CSL

174.73%

Free Cash Flow Yield

BBIO

-3.33%

Winner

CSL

6.94%

P/S Ratio

BBIO

23.04

Winner

CSL

2.67

P/B Ratio

BBIO

123.68

Winner

CSL

7.97

BBIO vs CSL - Historical Returns

Returns include dividend reinvestment.

Period	BBIO	CSL
1 month	-7.15%	-5.26%
3 months	+1.78%	-16.41%
6 months	+1.48%	+8.55%
1 year	+109.65%	-13.22%
5 years(CAGR)	+3.60%	+12.76%
10 years(CAGR)	N/A	+13.98%
Max(CAGR)	+14.26%	+13.73%

BBIO

-7.15%

Winner

CSL

-5.26%

Winner

BBIO

+1.78%

CSL

-16.41%

BBIO

+1.48%

Winner

CSL

+8.55%

Winner

BBIO

+109.65%

CSL

-13.22%

5Y(CAGR)

BBIO

+3.60%

Winner

CSL

+12.76%

10Y(CAGR)

BBIO

N/A

CSL

+13.98%

Max(CAGR)

Winner

BBIO

+14.26%

CSL

+13.73%

BBIO vs CSL - Annual Returns (1999 - 2026)

Returns include dividend reinvestment.

Year	BBIO	CSL
2026	-11.65%	+2.23%
2025	+171.24%	-11.66%
2024	-32.16%	+20.08%
2023	+463.04%	+35.04%
2022	-55.59%	-3.01%
2021	-73.79%	+62.98%
2020	+114.06%	-3.31%
2019	+27.22%	+62.36%
2018	N/A	-12.87%
2017	N/A	+5.48%
2016	N/A	+29.32%
2015	N/A	-0.33%
2014	N/A	+16.22%
2013	N/A	+32.88%
2012	N/A	+30.90%
2011	N/A	+11.21%
2010	N/A	+15.36%
2009	N/A	+64.68%
2008	N/A	-43.52%
2007	N/A	-5.44%
2006	N/A	+13.24%
2005	N/A	+10.86%
2004	N/A	+8.11%
2003	N/A	+44.81%
2002	N/A	+17.03%
2001	N/A	-9.48%
2000	N/A	+26.79%
1999	N/A	+10.53%

BBIO vs CSL Drawdown Comparison

The maximum drawdown for BBIO was -92.80%, occurring on May 11, 2022. Recovery took 1211 trading sessions.

The maximum drawdown for CSL was -64.55%, occurring on Nov 20, 2008. Recovery took 918 trading sessions.

The current BBIO drawdown is -13.50%. The current CSL drawdown is -29.20%.

Rank	BBIO	CSL
#1	-92.80% Feb 8, 2021 - Dec 3, 2025	-64.55% Sep 4, 2007 - Apr 26, 2011
#2	-65.45% Dec 23, 2019 - Nov 24, 2020	-45.55% Jun 29, 2000 - Oct 8, 2003
#3	-44.53% Sep 3, 2019 - Nov 20, 2019	-39.12% May 10, 2011 - Feb 21, 2012
#4	-21.99% Dec 31, 2020 - Feb 8, 2021	-38.68% Jan 2, 2020 - Mar 25, 2021
#5	-20.25% Jan 22, 2026 - Feb 5, 2026	-37.71% Oct 14, 2024 - Nov 20, 2025
#6	-16.79% Nov 22, 2019 - Dec 9, 2019	-34.51% Aug 18, 2022 - Dec 15, 2023
#7	-14.67% Jul 22, 2019 - Aug 26, 2019	-27.39% Aug 29, 2018 - Apr 18, 2019
#8	-12.87% Jul 11, 2019 - Jul 22, 2019	-25.34% Aug 17, 2015 - Apr 27, 2016
#9	-6.70% Dec 12, 2019 - Dec 18, 2019	-19.70% May 18, 2005 - Feb 9, 2006
#10	-6.15% Jan 2, 2026 - Jan 13, 2026	-19.47% Nov 25, 2016 - Nov 29, 2017
#11	-5.62% Jul 5, 2019 - Jul 11, 2019	-17.69% Jan 8, 2018 - Jul 25, 2018
#12	-5.28% Aug 27, 2019 - Sep 3, 2019	-15.01% May 4, 2022 - Jul 28, 2022
#13	-4.46% Dec 1, 2020 - Dec 4, 2020	-14.86% Jun 10, 2014 - Oct 30, 2014
#14	-4.45% Dec 18, 2019 - Dec 20, 2019	-14.45% Jul 16, 2024 - Sep 23, 2024
#15	-4.13% Dec 4, 2025 - Dec 12, 2025	-13.99% Jul 16, 2004 - Feb 3, 2005